Sold as Aldomet. Every FDA application for this active ingredient: 1 branded and 11 generic.
As of Nov 15, 2026, FDA lists 12 applications for Methyldopate Hydrochloride (sold as Aldomet), first approved Dec 20, 1962, with 0 new uses approved and 0 published complete response letters.
| Dec 20, 1962 | AldometNDA 13401 · New active ingredient | Merck | 31 | Discontinued |
| Jun 3, 1986 | Methyldopate HydrochlorideANDA 70652 | Abraxis Pharm | 1 | Discontinued |
| Jul 1, 1986 | Methyldopate HydrochlorideANDA 70291 | Baxter Hlthcare | 9 | Discontinued |
| Jun 15, 1987 | Methyldopate HydrochlorideANDA 70698 | Hospira | 18 | Discontinued |
| Jun 15, 1987 | Methyldopate HydrochlorideANDA 70699 | Hospira | 9 | Discontinued |
| Dec 2, 1987 | Methyldopate HydrochlorideANDA 71279 | Am Regent | 9 | Discontinued |
| Dec 22, 1987 | Methyldopate HydrochlorideANDA 71812 | Marsam Pharms LLC | 2 | Discontinued |
| Nov 22, 1991 | Methyldopate HydrochlorideANDA 72974 | Teva Parenteral | 2 | Discontinued |
| — | Methyldopate HydrochlorideANDA 70691 | Hospira | 0 | Discontinued |
| — | Methyldopate HydrochlorideANDA 70841 | Smith And Nephew | 0 | Discontinued |
| — | Methyldopate HydrochlorideANDA 70849 | Hospira | 0 | Discontinued |
| — | Methyldopate HclANDA 71024 | Quad Pharms | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA